US Body Pits Authorized Generics Against Competitors
Coalition Positions Authorized Products Against Traditional Generics
Pfizer’s Greenstone and Sanofi’s Winthrop have together founded a US industry body to represent authorized generics, drawing a distinction between these products and traditional generics.
You may also be interested in...
Innovent Biologics has broadened its international reach by striking a licensing deal with PT Etana Biotechnologies in Indonesia for its Byvasda bevacizumab biosimilar.
Guidance on protecting participants in bioequivalence studies during the COVID-19 pandemic has been published by the FDA.
Teva has launched its generic version of NuvaRing in the US, adding a second rival generic to the market that already includes Amneal, as well as an authorized generic version from Prasco.